These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32499580)

  • 1. Multispecific drugs: the fourth wave of biopharmaceutical innovation.
    Wang Y; Yang S
    Signal Transduct Target Ther; 2020 Jun; 5(1):86. PubMed ID: 32499580
    [No Abstract]   [Full Text] [Related]  

  • 2. Multispecific drugs herald a new era of biopharmaceutical innovation.
    Deshaies RJ
    Nature; 2020 Apr; 580(7803):329-338. PubMed ID: 32296187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personal adventures in biopharmaceutical research during the 1953-1984 years.
    Swintosky JV
    Drug Intell Clin Pharm; 1985 Apr; 19(4):265-76. PubMed ID: 3891277
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?
    Flanagan T; Van Peer A; Lindahl A
    Eur J Pharm Sci; 2016 Aug; 91():84-90. PubMed ID: 27283487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of benchmarking in the development of biopharmaceutical products.
    Giffin M; McLeish S
    Biotechnol Annu Rev; 2003; 9():279-84. PubMed ID: 14650932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovator Organizations in New Drug Development: Assessing the Sustainability of the Biopharmaceutical Industry.
    Kinch MS; Moore R
    Cell Chem Biol; 2016 Jun; 23(6):644-53. PubMed ID: 27341432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
    Lindenberg M; Kopp S; Dressman JB
    Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human in vivo regional intestinal permeability: importance for pharmaceutical drug development.
    Lennernäs H
    Mol Pharm; 2014 Jan; 11(1):12-23. PubMed ID: 24206063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
    Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
    Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery pharmaceutics--challenges and opportunities.
    Chen XQ; Antman MD; Gesenberg C; Gudmundsson OS
    AAPS J; 2006 Jun; 8(2):E402-8. PubMed ID: 16796392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biopharmaceutical properties of drugs and their bioavailability].
    Wislicki L
    Harefuah; 1975 Mar; 88(6):293-4. PubMed ID: 1132834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research of for the discovery of new drugs and research for the development and production of drugs].
    Setnikar I
    Boll Chim Farm; 1971 Sep; 110(9):503-9. PubMed ID: 5137987
    [No Abstract]   [Full Text] [Related]  

  • 14. Paediatric biopharmaceutics classification system: current status and future decisions.
    Batchelor H;
    Int J Pharm; 2014 Aug; 469(2):251-3. PubMed ID: 24602991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
    Hu H; Chung CC
    Int J Health Policy Manag; 2015 Sep; 4(12):823-9. PubMed ID: 26673466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The successes and challenges of open-source biopharmaceutical innovation.
    Allarakhia M
    Expert Opin Drug Discov; 2014 May; 9(5):459-65. PubMed ID: 24702304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies.
    Morar-Mitrica S; Adams ML; Crotts G; Wurth C; Ihnat PM; Tabish T; Antochshuk V; DiLuzio W; Dix DB; Fernandez JE; Gupta K; Fleming MS; He B; Kranz JK; Liu D; Narasimhan C; Routhier E; Taylor KD; Truong N; Stokes ESE
    J Pharm Sci; 2018 Feb; 107(2):529-542. PubMed ID: 29074375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biopharmaceutical aspects of pharmaceutical technology].
    Thoma K
    Pharmazie; 1981 Mar; 36(3):185-93. PubMed ID: 7279982
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical industry.
    Weiner M
    Pharmacology; 1972; 8(1):201-4. PubMed ID: 4644649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.